首页> Medical oncology (Northwood, London, England)> RUNX2 promotes the suppression of osteoblast function and enhancement of osteoclast activity by multiple myeloma cells.

RUNX2 promotes the suppression of osteoblast function and enhancement of osteoclast activity by multiple myeloma cells.

导出 OA

翻译打印收藏纠错

第一作者： Beihui,Huang

第一单位： Department of Hematopathology, The First Affiliated Hospital, Sun Yat-Sen University, No. 58, Zhongshan 2Nd Road, Guangzhou, 510080, China.

作者： Beihui,Huang ^[1] ; Huixin,Liu ^[1] ; Szehoi,Chan ^[2] ; Junru,Liu ^[1] ; Jingli,Gu ^[1] ; Meilan,Chen ^[1] ; Lifen,Kuang ^[1] ; Xiaozhe,Li ^[1] ; Xingding,Zhang ^[3] ; Juan,Li ^[4]

作者单位： Department of Hematopathology, The First Affiliated Hospital, Sun Yat-Sen University, No. 58, Zhongshan 2Nd Road, Guangzhou, 510080, China. ^[1] Department of Pharmacology, School of Medicine, Molecular Cancer Research Center, Sun Yat-Sen University, No.66, Gongchang Road, Shenzhen, 518107, China. ^[2] Department of Pharmacology, School of Medicine, Molecular Cancer Research Center, Sun Yat-Sen University, No.66, Gongchang Road, Shenzhen, 518107, China. zhangxd39@mail.sysu.edu.cn. ^[3] Department of Hematopathology, The First Affiliated Hospital, Sun Yat-Sen University, No. 58, Zhongshan 2Nd Road, Guangzhou, 510080, China. ljuan@mail.sysu.edu.cn. ^[4]

关键词 Bone destruction Multiple myeloma Osteoblast Osteoclast RUNX2